N-(4-amino-3,4-dioxo-1-phenylbutan-2-yl)-3-(1H-indazol-3-yl)imidazole-4-carboxamide;N-(4-amino-3,4-dioxo-1-phenylbutan-2-yl)-5-methyl-2-(3-methyl-2-pyridinyl)pyrazole-3-carboxamide;N-(4-amino-3,4-dioxo-1-phenylbutan-2-yl)-3-(1-phenylpyrazol-3-yl)imidazole-4-carboxamide;N-[4-(cyclopropylamino)-3,4-dioxo-1-phenylbutan-2-yl]-4-indazol-2-yl-1,3-thiazole-5-carboxamide;N-[4-(cyclopropylamino)-3,4-dioxo-1-phenylbutan-2-yl]-5-methyl-2-(3-methyl-2-pyridinyl)pyrazole-3-carboxamide;N-[4-(cyclopropylamino)-3,4-dioxo-1-phenylbutan-2-yl]-5-methyl-2-pyrimidin-2-ylpyrazole-3-carboxamide
C135H127N33O18S — CID 159962458
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-(4-amino-3,4-dioxo-1-phenylbutan-2-yl)-3-(1H-indazol-3-yl)imidazole-4-carboxamide;N-(4-amino-3,4-dioxo-1-phenylbutan-2-yl)-5-methyl-2-(3-methyl-2-pyridinyl)pyrazole-3-carboxamide;N-(4-amino-3,4-dioxo-1-phenylbutan-2-yl)-3-(1-phenylpyrazol-3-yl)imidazole-4-carboxamide;N-[4-(cyclopropylamino)-3,4-dioxo-1-phenylbutan-2-yl]-4-indazol-2-yl-1,3-thiazole-5-carboxamide;N-[4-(cyclopropylamino)-3,4-dioxo-1-phenylbutan-2-yl]-5-methyl-2-(3-methyl-2-pyridinyl)pyrazole-3-carboxamide;N-[4-(cyclopropylamino)-3,4-dioxo-1-phenylbutan-2-yl]-5-methyl-2-pyrimidin-2-ylpyrazole-3-carboxamide
N-(4-amino-3,4-dioxo-1-phenylbutan-2-yl)-3-(1H-indazol-3-yl)imidazole-4-carboxamide;N-(4-amino-3,4-dioxo-1-phenylbutan-2-yl)-5-methyl-2-(3-methyl-2-pyridinyl)pyrazole-3-carboxamide;N-(4-amino-3,4-dioxo-1-phenylbutan-2-yl)-3-(1-phenylpyrazol-3-yl)imidazole-4-carboxamide;N-[4-(cyclopropylamino)-3,4-dioxo-1-phenylbutan-2-yl]-4-indazol-2-yl-1,3-thiazole-5-carboxamide;N-[4-(cyclopropylamino)-3,4-dioxo-1-phenylbutan-2-yl]-5-methyl-2-(3-methyl-2-pyridinyl)pyrazole-3-carboxamide;N-[4-(cyclopropylamino)-3,4-dioxo-1-phenylbutan-2-yl]-5-methyl-2-pyrimidin-2-ylpyrazole-3-carboxamide (PubChem CID 159962458) has the molecular formula C135H127N33O18S and a molecular weight of 2531.78 g/mol. Its IUPAC name is N-(4-amino-3,4-dioxo-1-phenylbutan-2-yl)-3-(1H-indazol-3-yl)imidazole-4-carboxamide;N-(4-amino-3,4-dioxo-1-phenylbutan-2-yl)-5-methyl-2-(3-methyl-2-pyridinyl)pyrazole-3-carboxamide;N-(4-amino-3,4-dioxo-1-phenylbutan-2-yl)-3-(1-phenylpyrazol-3-yl)imidazole-4-carboxamide;N-[4-(cyclopropylamino)-3,4-dioxo-1-phenylbutan-2-yl]-4-indazol-2-yl-1,3-thiazole-5-carboxamide;N-[4-(cyclopropylamino)-3,4-dioxo-1-phenylbutan-2-yl]-5-methyl-2-(3-methyl-2-pyridinyl)pyrazole-3-carboxamide;N-[4-(cyclopropylamino)-3,4-dioxo-1-phenylbutan-2-yl]-5-methyl-2-pyrimidin-2-ylpyrazole-3-carboxamide.
Molecular Properties
| Compound Name | N-(4-amino-3,4-dioxo-1-phenylbutan-2-yl)-3-(1H-indazol-3-yl)imidazole-4-carboxamide;N-(4-amino-3,4-dioxo-1-phenylbutan-2-yl)-5-methyl-2-(3-methyl-2-pyridinyl)pyrazole-3-carboxamide;N-(4-amino-3,4-dioxo-1-phenylbutan-2-yl)-3-(1-phenylpyrazol-3-yl)imidazole-4-carboxamide;N-[4-(cyclopropylamino)-3,4-dioxo-1-phenylbutan-2-yl]-4-indazol-2-yl-1,3-thiazole-5-carboxamide;N-[4-(cyclopropylamino)-3,4-dioxo-1-phenylbutan-2-yl]-5-methyl-2-(3-methyl-2-pyridinyl)pyrazole-3-carboxamide;N-[4-(cyclopropylamino)-3,4-dioxo-1-phenylbutan-2-yl]-5-methyl-2-pyrimidin-2-ylpyrazole-3-carboxamide |
|---|---|
| PubChem CID | 159962458 |
| Molecular Formula | C135H127N33O18S |
| Molecular Weight | 2531.78 g/mol |
| Exact Mass | 2529.98 |
| IUPAC Name | N-(4-amino-3,4-dioxo-1-phenylbutan-2-yl)-3-(1H-indazol-3-yl)imidazole-4-carboxamide;N-(4-amino-3,4-dioxo-1-phenylbutan-2-yl)-5-methyl-2-(3-methyl-2-pyridinyl)pyrazole-3-carboxamide;N-(4-amino-3,4-dioxo-1-phenylbutan-2-yl)-3-(1-phenylpyrazol-3-yl)imidazole-4-carboxamide;N-[4-(cyclopropylamino)-3,4-dioxo-1-phenylbutan-2-yl]-4-indazol-2-yl-1,3-thiazole-5-carboxamide;N-[4-(cyclopropylamino)-3,4-dioxo-1-phenylbutan-2-yl]-5-methyl-2-(3-methyl-2-pyridinyl)pyrazole-3-carboxamide;N-[4-(cyclopropylamino)-3,4-dioxo-1-phenylbutan-2-yl]-5-methyl-2-pyrimidin-2-ylpyrazole-3-carboxamide |
| SMILES | Cc1cc(C(=O)NC(Cc2ccccc2)C(=O)C(=O)NC2CC2)n(-c2ncccc2C)n1.Cc1cc(C(=O)NC(Cc2ccccc2)C(=O)C(=O)NC2CC2)n(-c2ncccn2)n1.Cc1cc(C(=O)NC(Cc2ccccc2)C(=O)C(N)=O)n(-c2ncccc2C)n1.NC(=O)C(=O)C(Cc1ccccc1)NC(=O)c1cncn1-c1ccn(-c2ccccc2)n1.NC(=O)C(=O)C(Cc1ccccc1)NC(=O)c1cncn1-c1n[nH]c2ccccc12.O=C(NC1CC1)C(=O)C(Cc1ccccc1)NC(=O)c1scnc1-n1cc2ccccc2n1 |
| InChI | InChI=1S/C24H21N5O3S.C24H25N5O3.C23H20N6O3.C22H22N6O3.C21H18N6O3.C21H21N5O3/c30-20(23(31)26-17-10-11-17)19(12-15-6-2-1-3-7-15)27-24(32)21-22(25-14-33-21)29-13-16-8-4-5-9-18(16)28-29;1-15-7-6-12-25-22(15)29-20(13-16(2)28-29)23(31)27-19(14-17-8-4-3-5-9-17)21(30)24(32)26-18-10-11-18;24-22(31)21(30)18(13-16-7-3-1-4-8-16)26-23(32)19-14-25-15-28(19)20-11-12-29(27-20)17-9-5-2-6-10-17;1-14-12-18(28(27-14)22-23-10-5-11-24-22)20(30)26-17(13-15-6-3-2-4-7-15)19(29)21(31)25-16-8-9-16;22-19(29)18(28)16(10-13-6-2-1-3-7-13)24-21(30)17-11-23-12-27(17)20-14-8-4-5-9-15(14)25-26-20;1-13-7-6-10-23-20(13)26-17(11-14(2)25-26)21(29)24-16(18(27)19(22)28)12-15-8-4-3-5-9-15/h1-9,13-14,17,19H,10-12H2,(H,26,31)(H,27,32);3-9,12-13,18-19H,10-11,14H2,1-2H3,(H,26,32)(H,27,31);1-12,14-15,18H,13H2,(H2,24,31)(H,26,32);2-7,10-12,16-17H,8-9,13H2,1H3,(H,25,31)(H,26,30);1-9,11-12,16H,10H2,(H2,22,29)(H,24,30)(H,25,26);3-11,16H,12H2,1-2H3,(H2,22,28)(H,24,29) |
| InChIKey | ODMUNNPBLJXHKG-UHFFFAOYSA-N |
| XLogP | 9.78 |
| TPSA | 711.46 Ų |
| H-Bond Donors | 13 |
| H-Bond Acceptors | 39 |
| Rotatable Bonds | 46 |
| Heavy Atoms | 187 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2531.78 |
| LogP ≤ 5 | 9.78 |
| H-Bond Donors ≤ 5 | 13 |
| H-Bond Acceptors ≤ 10 | 39 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'diketo_group', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159962458 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.